JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4121 SNS-314 Mesylate

Target: Aurora Kinases

Summary: Aurora A/B/C kinases inhibitor, potent and selective

≥26.35 mg/mL
A4011 ONX-0914 (PR-957)
13 Citation

Target: Proteasome

Summary: Immunoproteasome inhibitor,potent and selective

≥29.03 mg/mL
A4310 Rosiglitazone HCl

Summary: PPARγ agonist

≥39.4 mg/mL
A4334 Avanafil
1 Citation

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL
A4386 Elesclomol (STA-4783)
3 Citation

Summary: Oxidative stress/apoptosis inducer,potent and novel

insoluble in H2O; ≥20.15 mg/mL
A3202 Avermectin B1

Summary: Insecticide

Soluble in DMSO
A3482 Icotinib Hydrochloride

Summary: EGFR inhibitor,potent and specific

Soluble in DMSO
A3561 Lu AE58054 Hydrochloride

Summary: 5-HT(6)R antagonist

≥21.74 mg/mL
A3724 PI-103 Hydrochloride
1 Citation

Target: PI3K|mTOR|DNA-PK

Summary: DNA-PK/PI 3-kinase/mTOR inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.25 mg/mL
A3740 Puromycin aminonucleoside
8 Citation

Summary: Aminonucleoside portion of the antibiotic puromycin

≥14.45 mg/mL